Innovation and R&D

Innovation Cooperation Platform

Home page

Innovation

Project Collaboration

In-/Out-Licensing

News Center

Viwit Pharmaceutical's Phenylephrine Hydrochloride Injection Officially Receives Official Approval by China NMPA

Viwit Pharmaceuticals’ Brimonidine tartrate and Timolol maleate eye drops receive Official Approval by China NMPA

Viwit's Nitroglycerin Sublingual Tablets Approved by FDA

Viwit Pharmaceuticals API Site Successfully Passed FDA cGMP On-site Audit with "No Action Indicated"

Viwit Pharmaceutical Co. Ltd. announces exclusive licensing and supply agreement for two Gadolinium based Magnetic Resonance Imaging (MRI) injectable contrast agents in the US.

Viwit Pharmaceutical’s Lifitegrast API has completed registrations in both China and the US!

Joint Venture

For partners with in-depth cooperation, we establish joint ventures (JV Partnership), share resources, and conduct all-round cooperation in research and development, marketing, fund raising and strategic development.

VIWIT

Technical Support:China Enterprise Cross-border | SEO Tags

【Business License】

Search